Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/02/2007 | US20070178166 Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration |
08/02/2007 | US20070178165 Processes for making particle-based pharmaceutical formulations for parenteral administration |
08/02/2007 | US20070178164 Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
08/02/2007 | US20070178163 Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof |
08/02/2007 | US20070178162 Process for production of ionically crosslinked polysaccharide microspheres |
08/02/2007 | US20070178161 Use of n-acetryl-d-glucosamine in treating and controlling non-specific inflammations caused by physical or chemical factors |
08/02/2007 | US20070178160 Gastro-intestinal device and method for treating addiction |
08/02/2007 | US20070178159 In-Situ Forming Porous Scaffold |
08/02/2007 | US20070178158 Stabilized bone graft |
08/02/2007 | US20070178157 Process for cleaning hard gelatine capsules |
08/02/2007 | US20070178156 Pharmaceutical formulations |
08/02/2007 | US20070178155 Preparation for gastric buoyant sustained drug release dosage form |
08/02/2007 | US20070178154 Calcium Carbonate Granulation |
08/02/2007 | US20070178153 Calcium Carbonate Granulation |
08/02/2007 | US20070178152 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
08/02/2007 | US20070178151 Spray dried pharmaceutical compositions |
08/02/2007 | US20070178150 Pharmaceutical compositions |
08/02/2007 | US20070178149 Levodopa compositions |
08/02/2007 | US20070178148 Preparations of growth hormone |
08/02/2007 | US20070178147 Liposomal compositions |
08/02/2007 | US20070178144 Cold-preparable, low-viscosity and prolonged-stability cosmetic emulsions |
08/02/2007 | US20070178141 Vitamin B12 compositions |
08/02/2007 | US20070178139 Vaginally administratable progesterone-containing tablets and method for preparing same |
08/02/2007 | US20070178124 Inorganic phosphates reversibly grafted with bioactive compounds and a method of their preparation |
08/02/2007 | US20070178123 Flavor-enhancing compositions, method of manufacture, and methods of use |
08/02/2007 | US20070178119 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier |
08/02/2007 | US20070178070 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease |
08/02/2007 | US20070178068 Compositions and methods for regulating complement system |
08/02/2007 | US20070178056 Mixture comprising a detergent and a co-detergent |
08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
08/02/2007 | US20070178051 Sterilized nanoparticulate glucocorticosteroid formulations |
08/02/2007 | US20070178050 Methods and systems for the delivery of corticosteroids having an increased lung depositon |
08/02/2007 | US20070178049 Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
08/02/2007 | US20070178048 administering an effective amount of p-menthane-3,8-diol (PMD) to destroy, inactivate, or inhibit the growth or reproduction of a virus (influenza virus, A/Sydney/5/97 virus, Urbani SARS virus and HSV-1 virus); antiseptic and antifungal agent; PMD rich extract derived from lemon eucalyptus |
08/02/2007 | US20070175472 Dpi formulation containing sulfoalkyl ether cyclodextrin |
08/02/2007 | DE19934943B4 Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen Cosmetic and dermatological preparations based on O / W emulsions |
08/02/2007 | DE10230558B4 Medizinisches Set zur Verabreichung in einer Kombinationstherapie Medical set for administration in combination therapy |
08/02/2007 | DE102006004353A1 Kaltherstellbare, niedrigviskose und langzeitstabile kosmetische Emulsionen Recoverable cold, low and stable long-term cosmetic emulsions |
08/02/2007 | DE102006003512A1 Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen Plate-like drugs for transbukkalen application of drugs |
08/02/2007 | CA2676483A1 Surface-layer protein coated microspheres and uses thereof |
08/02/2007 | CA2656829A1 Foaming granule and method for making same |
08/02/2007 | CA2640529A1 Chewable capsules |
08/02/2007 | CA2640376A1 Antimicrobial ceramic material comprising metal species |
08/02/2007 | CA2640165A1 A method of producing porous microparticles |
08/02/2007 | CA2640069A1 Chewable compositions comprising a gelled oil-in-water emulsion |
08/02/2007 | CA2639406A1 Methods of increasing oral bioavailability of tetracyclines |
08/02/2007 | CA2637925A1 Levetiracetam formulations and methods for their manufacture |
08/02/2007 | CA2637300A1 Pharmaceutical forms in film form for use in the mouth (wafers) |
08/02/2007 | CA2637275A1 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
08/02/2007 | CA2637274A1 Soft-gelatin capsule formulation |
08/02/2007 | CA2607494A1 Nanoparticulate clopidogrel formulations |
08/01/2007 | EP1813295A2 Coated surgical needles |
08/01/2007 | EP1813288A1 Medicinal composition, medicinal preparation, and combination preparation |
08/01/2007 | EP1813287A1 Type ii cubic liquid crystal composition |
08/01/2007 | EP1813277A1 Dispenser for dispensing two or more substances |
08/01/2007 | EP1813276A1 Tamper resistant dosage forms |
08/01/2007 | EP1813275A1 Lansoprazole orally disintegrating tablets |
08/01/2007 | EP1813274A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition |
08/01/2007 | EP1813273A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
08/01/2007 | EP1813272A1 Veterinary use of a lleuromutilin derivate againts ileitis in swine |
08/01/2007 | EP1813268A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds |
08/01/2007 | EP1812864A2 Multifunctional nanoparticles conjugates and their use |
08/01/2007 | EP1812494A1 Microparticles and nanoparticles containing a lipopolymer |
08/01/2007 | EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
08/01/2007 | EP1812079A2 Pharmaceutical mixture evaluation |
08/01/2007 | EP1812052A1 Methods of cancer treatment/prevention using cancer cell-specific surface antigens |
08/01/2007 | EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
08/01/2007 | EP1812032A2 Tissue factor composition and methods |
08/01/2007 | EP1812022A2 Stand-alone film and methods for making the same |
08/01/2007 | EP1812000A1 Aqueous ophthalmic suspension of crystalline rebamipide |
08/01/2007 | EP1811995A1 A transmucosal veterinary composition comprising detomidine |
08/01/2007 | EP1811986A1 Gabapentin prodrug sustained release oral dosage forms |
08/01/2007 | EP1811981A2 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister |
08/01/2007 | EP1811979A2 Microcapsules comprising a methylxanthine and a corticosteroid |
08/01/2007 | EP1811978A1 Production of double- or multi-layered microcapsules |
08/01/2007 | EP1811977A2 High concentration self-microemulsifying coenzyme q10 preparations for nutritional use |
08/01/2007 | EP1811976A1 Immediate release film coating |
08/01/2007 | EP1811975A2 Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid |
08/01/2007 | EP1811974A2 Pharmaceutical analysis apparatus and method |
08/01/2007 | EP1811973A1 Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol |
08/01/2007 | EP1811972A1 A controlled slow release formulation of thiamine and use thereof in the treatment of pathologies connected to defective process of learning and memorization |
08/01/2007 | EP1811971A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
08/01/2007 | EP1811970A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
08/01/2007 | EP1811969A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
08/01/2007 | EP1811968A2 Dosage forms having a microreliefed surface and methods and apparatus for their production |
08/01/2007 | EP1811967A2 Methods and formulations for making pharmaceutical compositions containing bupropion |
08/01/2007 | EP1811966A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
08/01/2007 | EP1811965A1 A process for preparing formulations of lipophilic active substances by spray freeze drying |
08/01/2007 | EP1811964A1 Granular compositions comprising solidified melt granules of a cox-2 selective inhibitor |
08/01/2007 | EP1811963A2 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
08/01/2007 | EP1811962A2 Manufacturing process for liposomal preparations |
08/01/2007 | EP1811961A2 Extended surface aggregates in the treatment of skin conditions |
08/01/2007 | EP1811960A2 Improvements in or relating to pharmaceutical compositions for local administration |
08/01/2007 | EP1811959A2 Ophthalmic compositions and methods for treating eyes |
08/01/2007 | EP1811958A2 Removal of impurities with supercritical fluids from ocular drug delivery devices during manufacturing |
08/01/2007 | EP1811957A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
08/01/2007 | EP1811956A1 Method of reducing nosocomial infections |
08/01/2007 | EP1811941A2 Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use |
08/01/2007 | EP1811855A1 Food supplement containing fish oil |
08/01/2007 | EP1638395A4 Physical mode of action pesticide |